BRAF V600Emutation in papillary thyroid carcinoma: its relation to clinical features and oncologic outcomes in a single cancer centre experience

Autor: Al-Masri, Mahmoud, Al-Shobaki, Tawfiq, Al-Najjar, Hani, Iskanderian, Rafal, Younis, Enas, Abdallah, Niveen, Tbakhi, Abdelghani, Haddad, Hussam, Al-Masri, Mohammad, Obeid, Zeinab, Jarrar, Awad

Publikováno v: Endocrine Connections; December 2021, Vol. 10 Issue: 12 p1531-1537, 7p

Germline Genetic Susceptibility Testing Among Emirati Nationals at Risk for Hereditary Breast and Ovarian Cancer Syndrome.

Autor: Rawashdeh RR; Oncology Institute, Cleveland Clinic Abu Dhabi, Abu Dhabi, United Arab Emirates., Pederson H; Genomic Medicine Institute and Center for Personalized Genetic Healthcare, Cleveland Clinic Main Campus, Cleveland, OH., Iskanderian R; Oncology Institute, Cleveland Clinic Abu Dhabi, Abu Dhabi, United Arab Emirates., Khan F; Oncology Institute, Cleveland Clinic Abu Dhabi, Abu Dhabi, United Arab Emirates., Altrabulsi B; Pathology and Laboratory Medicine Institute, Cleveland Clinic Abu Dhabi, Abu Dhabi, United Arab Emirates., Ricci S; Oncology Institute, Cleveland Clinic Abu Dhabi, Abu Dhabi, United Arab Emirates., Eng C; Genomic Medicine Institute and Center for Personalized Genetic Healthcare, Cleveland Clinic Main Campus, Cleveland, OH., Jallad B; Oncology Institute, Cleveland Clinic Abu Dhabi, Abu Dhabi, United Arab Emirates., Al Mannaei AI; Department of Health, Abu Dhabi, United Arab Emirates., Alameri MS; Department of Health, Abu Dhabi, United Arab Emirates., Attia A; Clinical Genomics, M42, Abu Dhabi, United Arab Emirates., Grobmyer SR; Oncology Institute, Cleveland Clinic Abu Dhabi, Abu Dhabi, United Arab Emirates.

Publikováno v: JCO global oncology [JCO Glob Oncol] 2024 Nov; Vol. 10, pp. e2400352. Date of Electronic Publication: 2024 Nov 14.

Outcomes and Impact of a Universal COVID-19 Screening Protocol for Asymptomatic Oncology Patients.

Autor: Iskanderian RR; Oncology Institute, Cleveland Clinic Abu Dhabi, Abu Dhabi, United Arab Emirates.; Digestive Disease Institute, Cleveland Clinic Abu Dhabi, Abu Dhabi, United Arab Emirates.; Cleveland Clinic Lerner College of Medicine, Case Western Reserve University, Ohio, United States of America., Karmstaji A; Digestive Disease Institute, Cleveland Clinic Abu Dhabi, Abu Dhabi, United Arab Emirates., Mohamed BK; Digestive Disease Institute, Cleveland Clinic Abu Dhabi, Abu Dhabi, United Arab Emirates., Alahmed S; Digestive Disease Institute, Cleveland Clinic Abu Dhabi, Abu Dhabi, United Arab Emirates., Masri MH; Oncology Institute, Cleveland Clinic Abu Dhabi, Abu Dhabi, United Arab Emirates.; Cleveland Clinic Lerner College of Medicine, Case Western Reserve University, Ohio, United States of America., Choufani E; Oncology Institute, Cleveland Clinic Abu Dhabi, Abu Dhabi, United Arab Emirates.; Cleveland Clinic Lerner College of Medicine, Case Western Reserve University, Ohio, United States of America., Ahmed N; Digestive Disease Institute, Cleveland Clinic Abu Dhabi, Abu Dhabi, United Arab Emirates.; Cleveland Clinic Lerner College of Medicine, Case Western Reserve University, Ohio, United States of America., Al-Shamsi HO; Medical Oncology Department, Alzahra Hospital Dubai, Dubai, United Arab Emirates.; College of Medicine, University of Sharjah, Sharjah, United Arab Emirates.; Emirates Oncology Society, Dubai, United Arab Emirates., Grobmyer SR; Oncology Institute, Cleveland Clinic Abu Dhabi, Abu Dhabi, United Arab Emirates.; Cleveland Clinic Lerner College of Medicine, Case Western Reserve University, Ohio, United States of America.

Publikováno v: The Gulf journal of oncology [Gulf J Oncolog] 2020 Sep; Vol. 1 (34), pp. 7-12.